Three Cases of Ticlopidine-induced Cholestatic Hepatitis
Journal of the Korean Neurological Association
;
: 434-436, 2002.
Artículo
en Coreano
| WPRIM
| ID: wpr-227407
ABSTRACT
Ticlopidine hydrochloride is world-wide used antiplatelet agent that inhibit ADP pathway. Its clinical side effects are the change of the blood picture, allergic skin reaction and gastrointestinal symptoms. We report three patients with severe cholestatic hepatitis caused by ticlopidine. They developed jaundice about 20days after taking ticlopidine (500 mg/day). Infectious and immunological etiologies were excluded by serology. There was no history of alcohol or drug abuse. Their symptoms were gradually subsided for a few months after discontinuing ticlopidine.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Piel
/
Ticlopidina
/
Adenosina Difosfato
/
Trastornos Relacionados con Sustancias
/
Hepatitis
/
Ictericia
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Neurological Association
Año:
2002
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS